Merck: Miracle Cures and Massive Scandals

From a 17th-century pharmacy to a global powerhouse, explore the duality of Merck & Co.—the creators of Keytruda and the center of the Vioxx disaster.[INTRO]ALEX: Imagine you're a CEO in the 1980s, and your scientists have developed a miracle drug that cures river blindness, a disease devastating millions. Instead of selling it, you decide to give it away for free—forever.JORDAN: Wait, a pharmaceutical company just giving away a blockbuster product? That sounds like a plot from a movie, not a Fortune 500 strategy.ALEX: It actually happened at Merck & Co. Though, as we’ll see, this same company also navigated one of the deadliest drug scandals in history. Today, we’re looking at Merck, the giant that defined modern medicine while wrestling with its own soul.[CHAPTER 1 - Origin]ALEX: The Merck story doesn't start in a high-tech lab in New Jersey. It starts in 1668, at a small pharmacy in Darmstadt, Germany, called the "Angel Pharmacy."JORDAN: 1668? That’s before the United States was even a country. How did a German apothecary become an American household name?ALEX: It was a family business for over two centuries. Then, in 1891, George Merck moved to New York to set up a U.S. branch to import chemicals from the family mothership.JORDAN: So, it was just a subsidiary. When did the divorce happen?ALEX: World War I changed everything. In 1917, the U.S. government seized the American branch under the Trading with the Enemy Act. They basically ripped the company away from its German parents and sold it off to American investors.JORDAN: That explains why there are two Mercks today. One in Germany and one in New Jersey, right?ALEX: Exactly. They’ve been fighting over the name ever since. If you’re in the U.S. or Canada, Merck is the American company. Everywhere else, they have to call themselves MSD, or Merck Sharp & Dohme, because the German original owns the name internationally.[CHAPTER 2 - Core Story]ALEX: After the split, the American Merck didn't just survive; it became the world’s R&D engine. They helped mass-produce penicillin for World War II and literally wrote the book on medicine—the Merck Manual is still the world’s best-selling medical textbook.JORDAN: So they were the "good guys" of Big Pharma? That reputation usually has a shelf life.ALEX: It hit a peak in the 80s under CEO Roy Vagelos. He’s the one who started the Mectizan program to donate river blindness drugs. He famously said, "Medicine is for the people... not for the profits." But then came the late 90s, and a drug called Vioxx.JORDAN: I remember hearing about Vioxx. That was a massive painkiller, right?ALEX: It was a "super aspirin." It promised to kill pain without hurting your stomach. It was a multi-billion dollar hit, but there was a hidden cost. Internal data started showing that Vioxx significantly increased the risk of heart attacks and strokes.JORDAN: Did they pull it immediately?ALEX: Not exactly. They kept it on the market for five years while evidence mounted. When they finally pulled it in 2004, it caused a total collapse in their reputation. Merck eventually paid nearly five billion dollars to settle tens of thousands of lawsuits.JORDAN: That’s a long fall from "medicine for the people."ALEX: It was a wake-up call. But they staged a comeback through a completely different field: immunotherapy. They developed a drug called Keytruda that essentially teaches your own immune system to hunt and kill cancer cells.JORDAN: Since cancer isn't going anywhere, I'm guessing that was a financial win too?ALEX: Huge. In 2024, Keytruda alone accounted for almost half of Merck’s entire revenue—nearly 30 billion dollars. It’s one of the best-selling drugs in human history.[CHAPTER 3 - Why It Matters]JORDAN: So, where does that leave Merck today? Are they the savior with the cancer cure or the giant with a pricing problem?ALEX: Honestly, both. Merck is the perfect case study for the "blockbuster" business model. They spend billions on R&D—over 13 billion in a single year—to find one miracle drug. But because that research is so expensive, they charge high prices, which fuels a massive debate over who can actually afford to stay alive.JORDAN: Right, Keytruda costs something like ten thousand dollars a month. It’s a literal life-saver, but only if you have the coverage or the cash.ALEX: That’s the tension. They also make Gardasil, the vaccine that has drastically reduced HPV and cervical cancer rates. They are pushing the boundaries of what’s scientifically possible while existing in a world where profit margins dictate which diseases get researched.[OUTRO]JORDAN: If we're looking at the whole history—from the Angel Pharmacy to the Vioxx scandal—what’s the one thing to remember about Merck?ALEX: Remember that Merck embodies the ultimate pharmaceutical trade-off: they provide the world's most innovative medical breakthroughs, but those miracles come with high costs and even higher corporate stakes.JORDAN: That’s Wikipodia — every story, on demand. Search your next topic at wikipodia.ai.